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P U B L I S H E D B Y E L S E V I E R I N C .LETTERS TO THE EDITORThe Eustachian Ridge:
Not an Innocent BystanderA prominent right atrial Eustachian ridge (ER), which
inserts into the roof of the fossa ovalis (FO), can
impede successful placement of a patent foramen
ovale (PFO) closure device, resulting in residual
shunting. This can be mitigated by selecting a more
ﬂexible or smaller device, illustrated by the following
clinical case. Although the precise prevalence is un-
known in a consecutive series of 73 patientsFIGURE 1 Examples of PFO Anatomy With a Prominent High ER Wit
(A) Left atrial (LA) view, white arrow shows patent foramen ovale (PFO
(ER); LA view angled to further demonstrate PFO opening; residual shunt
on 2-dimensional (2D) transesophageal echocardiography (TEE) color D
shows partially obscured FO and black dotted line shows ER; superior vie
TEE shows ER attaching to superior border of FO and white arrow shows
Inc.), 25 mm. LA view, red star shows guidewire through PFO; RA view, s
shows device partially resting on ER; LA view of device; 2D TEE shows
appearance, allowing accommodation of ER anatomy with complete PFO
red star shows guidewire through PFO; RA view, white line shows parti
guidewire through PFO; LA view, device and 4 “propeller” arms of the LA
RA view, device square-shaped RA anchor, with 1 corner resting on ER, w
aortic root; CS ¼ coronary sinus; IVC ¼ inferior vena cava; MV ¼ mitral vundergoing PFO closure in our institution, over
18 months we observed this type of anatomy in
23 patients (32%), using 3-dimensional trans-
esophageal echocardiography (3D TEE). A 3D TEE
assessment is usually performed pre-procedure to
allow us to plan an implant strategy; however, we
have a range of device types and sizes available at the
time of PFO closure. If a prominent high ER is
present, we are in a position to consider a smaller and
softer device that conforms to this anatomy and will
rest ﬂush with the septum.
A 45-year-old woman suffered an embolic stroke.
She underwent PFO closure using a 25-mm Amplatzer
PFO occluder device (St. Jude Medical, Inc., St. Paul,
Minnesota) (Figure 1A). At 6 months, a routine agitatedh and Without a Closure Device In Situ, Using 2D and 3D TEE
) opening; right atrial (RA) view, RA disc resting on Eustachian ridge
ing at anterior border of the Amplatzer device (St. Jude Medical, Inc.)
oppler. (B) LA view, red dotted line indicates PFO opening; RA view
w LA side, white arrow shows PFO opening and red star shows ER; 2D
PFO opening into LA. (C) Gore Helex device (W. L. Gore & Associates,
hows partially obscured FO and black dotted line shows ER; RA view
device partially unfolded RA disc, red arrows, giving a bulbous
closure. (D) Premere device (St. Jude Medical, Inc.), 20 mm. LA view,
ally obscured FO, black dotted line shows ER, and red star shows
anchor of the device can be seen, 2 are demarcated red dotted lines;
hite star; Premere device (St. Jude Medical) as seen on 2D TEE. AO ¼
alve; RUPV ¼ right upper pulmonary vein; SVC ¼ superior vena cava.
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1063saline transthoracic echocardiography study showed a
signiﬁcantly larger shunt than pre-PFO closure. 3D
TEE demonstrated residual shunting from the supe-
rior aspect of the left atrial disc (white arrow). The
right atrial (RA) 3D TEE view revealed a prominent
ridge of solid tissue, the ER (black dotted line), pre-
venting the RA disc (white dotted line) from resting
ﬂush on the FO because the FO was partially obscured
at its anterosuperior border by the high insertion of
the ER. Flow was seen from the inferior edge of the RA
disc through the PFO, which was “held open” by the
“rigid” device.
A further example of this anatomy is shown in
Figure 1B. To achieve complete PFO closure, we found
either a softer more compliant device (Gore Helex
septal occluder, W. L. Gore & Associates, Inc., Flag-
staff, Arizona) (Figure 1C) or a smaller device where
the left and right atrial discs can be placed indepen-
dently (Premere device from St. Jude Medical, St.
Paul, Minnesota) (Figure 1D) to be better suited. The
identiﬁcation of a prominent ER is essential to guide
optimal device selection.Anna C. Kydd, MD
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and Computed Tomography Angiography for
Prediction of Cardiovascular EventsWe compared coronary magnetic resonance angiog-
raphy (CMRA) and coronary multislice computed
tomography angiography (CTA) for prediction ofcardiac events in patients with suspected or known
coronary artery disease (CAD) scheduled for elective
coronary angiography (ICA).
We included 110 consecutive patients with sus-
pected or known CAD scheduled for ICA, reported in a
previous study (1). Thirty-three (30%) had prior CAD.
Each patient was examined in a clinical 3.0-T cardiac
magnetic resonance (CMR) scanner (Achieva 3
Tesla, Philips, Best, the Netherlands) and a 64-slice
computed tomography scanner (SOMATOM Sensa-
tion 64, Siemens Healthcare, Erlangen, Germany).
Coronary assessment was performed as described
previously (1). Follow-up data were collected by
reviewing clinical records or by phone interviews.
Cardiac events were deﬁned as cardiovascular death,
nonfatal myocardial infarction, need for revasculari-
zation, invasive angiography, or hospitalization
attributable to cardiac causes. Events that occurred in
the ﬁrst 3 months were excluded.
Sixty-two patients (56.4%) had at least 1 signiﬁ-
cant lesion (50% luminal diameter stenosis in
segments $1.5 mm with quantitative ICA as refer-
ence). Thirty-four (30.9%) had 1-vessel disease,
17 (15.5%) had 2-vessel disease, and 11 (10%) had
3-vessel or left main (LM) disease (1). The follow-up
was 40  16 months. Thirty-seven cardiac events
were recorded, including 1 cardiac death (0.9%),
4 myocardial infarctions (3.6%), surgical revasculari-
zation (9 [8.2%]), or percutaneous revascularization
(14 [12.7%]), and ICA or hospitalization (9 [8.2%]).
Seven events that occurred in the ﬁrst 3 months were
excluded; 30 events were analyzed.
No signiﬁcant differences in event-free survival
were observed between coronary CTA and CMRA
(log-rank test p ¼ 0.97). No differences were observed
when the analysis was performed based on the
number of vessels affected (3-vessel or LM disease,
p ¼ 0.97; 2-vessel disease, p ¼ 0.60; and 1-vessel
disease, p ¼ 0.340) or per-vessel (right coronary,
p ¼ 0.79; LM, p ¼ 0.99; left anterior descendent,
p ¼ 0.97; and circumﬂex, p ¼ 0.99). The hazard ratio
was 4.69 (95% conﬁdence interval: 1.80 to 12.24,
p ¼ 0.002) for positive versus negative coronary CTA
and 3.17 (95% conﬁdence interval: 1.36 to 7.36,
p ¼ 0.007) for CMRA (Figure 1).
Our ﬁndings were as follows: 1) the absence of
coronary stenosis in CMRA or coronary CTA identiﬁes
patients at low risk for cardiac events; and 2) in
patients with suspected or known CAD already
scheduled for ICA, CMRA and coronary CTA provide
similar prognostic information on an intraindividual
basis.
The prognostic value of CMRA is not well known.
One study (2) demonstrated more cardiac events in
